Michał Machowski, Aisha Ou-Pokrzewińska, Katarzyna Perzanowska-Brzeszkiewicz, Magdalena Gałecka-Nowak, Szymon Pacho, Mateusz Jermakow, Agnieszka Wójcik, Milena Zoruk, Andrzej Pruszczyk, Karol Deutsch, Marek Roik, Andrzej Łabyk, Piotr Palczewski, Piotr Pruszczyk
BACKGROUND COVID-19 increases the risk of acute cardiovascular diseases (CVDs), including acute coronary syndrome (ACS), acute pulmonary embolism (APE), and acute myocarditis (AMyo). The actual impact of CVDs on mortality of patients with COVID-19 remains unknown. This study aimed to determine whether CVDs influence the course of COVID-19 pneumonia and if they can be easily detected by using common tests and examinations. MATERIAL AND METHODS Data of 249 consecutive patients with COVID-19 hospitalized in a dedicated cardiology department were analyzed...
April 22, 2024: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research